Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2012

01.02.2012 | Retinal Disorders

Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort

verfasst von: Luciana N. Almeida, Rachel Melilo-Carolino, Carlos E. Veloso, Patrícia A. Pereira, Debora M. Miranda, Luiz Armando De Marco, Marcio Bittar Nehemy

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the association between VEGF gene polymorphism and age-related macular degeneration (AMD) in a Brazilian cohort.

Methods

We examined 160 affected individuals and 140 sex- and age-matched controls recruited at the Vision Institute and the Retina Department, São Geraldo Hospital, Minas Gerais Federal University, Brazil, between 2007 and 2011. Genotyping for the VEGF rs1413711 single nucleotide polymorphism (SNP) (+674C>T) was performed. The incidence rate ratios and 95% confidence interval (CI) for AMD for this genotype was calculated. The odds ratio (OR) was also assessed by using logistic regression, controlling for CFH and LOC387715 risk genotype.

Results

We observed a prevalence of homozygosity (TT genotype) of 18.1% for rs1413711 among AMD cases compared with 5.8% among controls (P < 0.002). The ORs for this polymorphism were 3.6 (95%CI 1.6–8.2) for homozygous subjects and 1.5 (95%CI 1.1–2.1, P < 0.01) if the subject had at least one risk allele. When we studied separately exudative and dry AMD groups, this polymorphism was statistically significant for both groups. Controlling for CFH and LOC387715 risk genotype the OR was 3.0 for VEGF homozygous, and the OR increases if the patient is homozygous for the three genes.

Conclusion

The present data suggests that VEGF TT genotype is associated with AMD among Brazilian patients.
Literatur
1.
Zurück zum Zitat Seddon JM, Chen CA (2006) Epidemiology of age-related macular degeneration. In: Ryan SJ (ed) Retina. Elsevier, California, pp 1017–1025 Seddon JM, Chen CA (2006) Epidemiology of age-related macular degeneration. In: Ryan SJ (ed) Retina. Elsevier, California, pp 1017–1025
2.
Zurück zum Zitat Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50:5818–5827PubMedCrossRef Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50:5818–5827PubMedCrossRef
3.
Zurück zum Zitat Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B (2009) Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50:2044–2053PubMedCrossRef Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B (2009) Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50:2044–2053PubMedCrossRef
4.
Zurück zum Zitat Almeida LNF, Carolino RM, Sperandio DC, Nehemy MB, De Marco LA (2009) The role of molecular genetic factors in age-related macular degeneration. Arq Bras Oftalmol 72:567–572PubMedCrossRef Almeida LNF, Carolino RM, Sperandio DC, Nehemy MB, De Marco LA (2009) The role of molecular genetic factors in age-related macular degeneration. Arq Bras Oftalmol 72:567–572PubMedCrossRef
5.
Zurück zum Zitat Hecker LA, Edwards AO, Ryu E, Tosakulwong N, Baratz KH, Brown WL, Charbel Issa P, Scholl HP, Pollok-Kopp B, Schmid-Kubista KE, Bailey KR, Oppermann M (2010) Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 19:209–215PubMedCrossRef Hecker LA, Edwards AO, Ryu E, Tosakulwong N, Baratz KH, Brown WL, Charbel Issa P, Scholl HP, Pollok-Kopp B, Schmid-Kubista KE, Bailey KR, Oppermann M (2010) Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 19:209–215PubMedCrossRef
6.
Zurück zum Zitat Lee AY, Kulkarni M, Fang AM, Edelstein S, Osborn MP, Brantley MA (2010) The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration. Br J Ophthalmol 94:915–917PubMedCrossRef Lee AY, Kulkarni M, Fang AM, Edelstein S, Osborn MP, Brantley MA (2010) The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration. Br J Ophthalmol 94:915–917PubMedCrossRef
7.
Zurück zum Zitat Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125:55–62PubMedCrossRef Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125:55–62PubMedCrossRef
8.
Zurück zum Zitat Wang G, Spencer KL, Court BL, Olson LM, Scott WK, Haines JL, Pericak-Vance MA (2009) Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci 50:3084–3090PubMedCrossRef Wang G, Spencer KL, Court BL, Olson LM, Scott WK, Haines JL, Pericak-Vance MA (2009) Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci 50:3084–3090PubMedCrossRef
9.
Zurück zum Zitat Jiang H, Qu Y, Dang G, Zhang X, Yin N, Zhang Y, Bi H, Pan X, Xu X, Zhou F, Dai H (2009) Analyses of single nucleotide polymorphism and haplotype linkage of LOC387715 and the HTRA1 gene in exudative age-related macular degeneration in a Chinese cohort. Retina 29:974–979PubMedCrossRef Jiang H, Qu Y, Dang G, Zhang X, Yin N, Zhang Y, Bi H, Pan X, Xu X, Zhou F, Dai H (2009) Analyses of single nucleotide polymorphism and haplotype linkage of LOC387715 and the HTRA1 gene in exudative age-related macular degeneration in a Chinese cohort. Retina 29:974–979PubMedCrossRef
10.
Zurück zum Zitat Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA (2006) Functional candidate genes in age-related macular degeneration: significant association with VEGF, VDRLR, and LRP6. Invest Ophthalmol Vis Sci 47:329–335PubMedCrossRef Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA (2006) Functional candidate genes in age-related macular degeneration: significant association with VEGF, VDRLR, and LRP6. Invest Ophthalmol Vis Sci 47:329–335PubMedCrossRef
11.
Zurück zum Zitat Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, Ray DW (2006) VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15:2955–2961PubMedCrossRef Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, Ray DW (2006) VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 15:2955–2961PubMedCrossRef
12.
Zurück zum Zitat Janik-Papis K, Zaras M, Krzyzanowska A, Wozniak K, Blasiak J, Szaflik J, Szaflik JP (2009) Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Exp Mol Pathol 87:234–238PubMedCrossRef Janik-Papis K, Zaras M, Krzyzanowska A, Wozniak K, Blasiak J, Szaflik J, Szaflik JP (2009) Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Exp Mol Pathol 87:234–238PubMedCrossRef
13.
Zurück zum Zitat Richardson AJ, Islam FM, Guymer RH, Cain M, Baird PN (2007) A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 26:2148–2152 Richardson AJ, Islam FM, Guymer RH, Cain M, Baird PN (2007) A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis 26:2148–2152
14.
Zurück zum Zitat Boekhoorn SS, Isaacs A, Uitterlinden AG, van Duijn CM, Hofman A, de Jong PT, Vingerling JR (2008) Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study. Ophthalmology 115:1899–1903PubMedCrossRef Boekhoorn SS, Isaacs A, Uitterlinden AG, van Duijn CM, Hofman A, de Jong PT, Vingerling JR (2008) Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study. Ophthalmology 115:1899–1903PubMedCrossRef
15.
Zurück zum Zitat Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO (2009) The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans 37:1207–1213PubMedCrossRef Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO (2009) The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans 37:1207–1213PubMedCrossRef
16.
Zurück zum Zitat Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27:331–371PubMedCrossRef Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27:331–371PubMedCrossRef
17.
Zurück zum Zitat Frank RN (1997) Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 29:341–353PubMedCrossRef Frank RN (1997) Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 29:341–353PubMedCrossRef
18.
Zurück zum Zitat Eyetech Study Group (2003) Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 110:979–986CrossRef Eyetech Study Group (2003) Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 110:979–986CrossRef
19.
Zurück zum Zitat Seddon JM, Sharma S, Adelman RA (2006) Evaluation of clinical age-related maculopathy staging system. Ophthalmology 113:260–266PubMedCrossRef Seddon JM, Sharma S, Adelman RA (2006) Evaluation of clinical age-related maculopathy staging system. Ophthalmology 113:260–266PubMedCrossRef
20.
Zurück zum Zitat Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tseng SH, Tsai FJ (2008) Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 145:1045–1051PubMedCrossRef Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tseng SH, Tsai FJ (2008) Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 145:1045–1051PubMedCrossRef
21.
Zurück zum Zitat Galan A, Ferlin A, Caretti L, Buson G, Sato G, Frigo AC, Foresta C (2010) Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 117:1769–1774PubMedCrossRef Galan A, Ferlin A, Caretti L, Buson G, Sato G, Frigo AC, Foresta C (2010) Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 117:1769–1774PubMedCrossRef
22.
Zurück zum Zitat Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA Jr (2009) Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis 10:2710–2719 Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA Jr (2009) Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis 10:2710–2719
23.
Zurück zum Zitat Pugh CW, Ratcliffe P (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677–684PubMedCrossRef Pugh CW, Ratcliffe P (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677–684PubMedCrossRef
24.
Zurück zum Zitat Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880–887PubMedCrossRef Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880–887PubMedCrossRef
Metadaten
Titel
Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort
verfasst von
Luciana N. Almeida
Rachel Melilo-Carolino
Carlos E. Veloso
Patrícia A. Pereira
Debora M. Miranda
Luiz Armando De Marco
Marcio Bittar Nehemy
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2012
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1807-5

Weitere Artikel der Ausgabe 2/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.